Veritable, L.P. Horizon Therapeutics Public LTD CO Transaction History

Veritable, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $23,581 - $34,558	-297 Reduced 9.48%	2,835 $226,000
Q1 2022 May 11, 2022	SELL	$86.42 - $109.81 $13,308 - $16,910	-154 Reduced 4.69%	3,132 $330,000
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $118,567 - $144,251	-1,203 Reduced 26.8%	3,286 $354,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $24,080 - $28,916	-262 Reduced 5.51%	4,489 $492,000
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $18,800 - $20,910	-218 Reduced 4.39%	4,751 $445,000
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $125,487 - $166,803	-1,747 Reduced 26.01%	4,969 $457,000
Q4 2020 Feb 11, 2021	BUY	$67.0 - $84.39 $469 - $590	7 Added 0.1%	6,716 $491,000
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $48,933 - $70,817	-886 Reduced 11.67%	6,709 $521,000
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $20,656 - $38,974	-684 Reduced 8.26%	7,595 $422,000
Q1 2020 May 13, 2020	SELL	$24.87 - $38.56 $1,541 - $2,390	-62 Reduced 0.74%	8,279 $245,000
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $212,111 - $305,864	8,341 New	8,341 $302,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.